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Higher body mass index is associated 
with larger postoperative improvement 
in patient-reported outcomes following total 
knee arthroplasty
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Abstract 
Background: Total knee arthroplasty is known to successfully alleviate pain and improve function in endstage knee 
osteoarthritis. However, there is some controversy with regard to the influence of obesity on clinical benefits after TKA. 
The aim of this study was to investigate the impact of body mass index (BMI) on improvement in pain, function and 
general health status following total knee arthroplasty (TKA).
Methods: A single-centre retrospective analysis of primary TKAs performed between 2006 and 2016 was performed. 
Data were collected preoperatively and 12-month postoperatively using WOMAC score and EQ-5D. Longitudinal 
score change was compared across the BMI categories identified by the World Health Organization.
Results: Data from 1565 patients [mean age 69.1, 62.2% women] were accessed. Weight distribution was: 21.2% 
BMI < 25.0 kg/m2, 36.9% BMI 25.0–29.9 kg/m2, 27.0% BMI 30.0–34.9 kg/m2, 10.2% BMI 35.0–39.9 kg/m2, and 4.6% 
BMI ≥ 40.0 kg/m2. All outcome measures improved between preoperative and 12-month follow-up (p < 0.001). In 
pairwise comparisons against normal weight patients, patients with class I-II obesity showed larger improvement on 
the WOMAC function and total score. For WOMAC pain improvements were larger for all three obesity classes.
Conclusions: Post-operative improvement in joint-specific outcomes was larger in obese patients compared to nor-
mal weight patients. These findings suggest that obese patients may have the greatest benefits from TKA with regard 
to function and pain relief one year post-op. Well balanced treatment decisions should fully account for both: Higher 
benefits in terms of pain relief and function as well as increased potential risks and complications.
Trial registration
This trial has been registered with the ethics committee of Eastern Switzerland (EKOS; Project-ID: EKOS 2020–00,879)
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Background
Osteoarthritis (OA) is a major global cause of disability, 
with the knee being the most frequently affected joint 
[1]. Total knee arthroplasty (TKA) is successful in alle-
viating the pain and disability associated with knee OA, 
and is one of the most commonly performed elective 
surgical procedures in orthopaedics [2]. The improve-
ments in patient health status achieved by TKA have 
been reported comparable to coronary revascularisa-
tion and renal transplant procedures [3]. Due to its well 
documented success, the number of TKAs performed 
increases every year and operative rates are reported to 
have doubled in the last decade [4, 5].
There is an established association between the 
patients’ body mass index (BMI) and knee OA, possibly 
due to increased mechanical loading at the joint [6–8]. 
Increased BMI is suggested to be one of the main modifi-
able risk factors of knee OA, given that every kilogram 
of weight loss leads to a fourfold reduction in the load 
exerted on the knee with daily activities [7]. Preoperative 
weight loss was found to have considerable implications 
for patient burden and cost reduction. [9]. High BMI is 
also associated with a variety of metabolic disturbances 
such as coronary heart disease, hypertension and diabe-
tes [7, 10] that could result in systemic risk factors for 
OA. Consequently, patients with increased BMI are more 
likely to require total knee arthroplasty (TKA) at younger 
age than patients with normal BMI [11]. Worldwide lev-
els of obesity (BMI > 30  kg/m2 by WHO definition) are 
rising rapidly [12, 13]. A quarter of the population of 
developed countries are reported as being obese [14]. By 
2030, the respective number of overweight (BMI > 25 kg/
m2) and obese (BMI > 30 kg/m2) adults is projected to be 
1.35 billion and 573 million individuals [12, 15]. Although 
increased BMI has been linked to the need for TKA, the 
impact of BMI on outcomes after TKA is less well estab-
lished [2, 6, 8, 16–20]. Patients with an increased BMI 
have been reported higher in-hospital discharge rates 
[21] and are accepted to have higher risks of postopera-
tive wound dehiscence [22], infection [16, 22, 23], com-
plications, and revision [6, 20, 24, 25]. These risks are 
often compounded by the associated comorbidities [20] 
or other factors like socioeconomic status [26] frequently 
found in such patients. It is not clear though whether 
BMI is associated with worse patient reported outcomes 
following TKA, as both equivalent outcomes [27, 28] and 
lower absolute post-operative scores [17, 19, 29] have 
been proposed scaled by BMI class using various metrics.
The objective of this study was to investigate the 
impact of preoperative BMI on postoperative improve-
ment in pain, function and general health status follow-
ing total knee arthroplasty (TKA) from the patients’ 
perspective.
Methods
The study was performed at a large teaching hospital in 
Switzerland; a higher-income country with a largely white 
European population. Ethics approval was obtained from 
the local ethics committee (ethics committee of Eastern 
Switzerland EKOS; Project-ID: EKOS 2020–00,879). Data 
from the local knee arthroplasty register was accessed 
and all patients undergoing elective primary total knee 
arthroplasty between 2006 and 2016 were considered 
for inclusion. Simultaneous bilateral surgery or incom-
plete data sets were criteria for patient exclusion. No 
patients were precluded from surgery or restricted from 
study inclusion due to their BMI. On an individual basis, 
depending on symptom burden and mobility, morbidly 
obese patients were referred to weight loss programs 
prior to surgery. Surgery was performed by consultant 
orthopaedic surgeons and their supervised trainees. Sur-
gery was performed in spinal or general anesthesia. Anti-
biotic prophylaxis using  3rd generation cephalosporin 
was administered in every case. A tourniquet was applied 
and inflated for insertion of the cemented implant. A 
medial parapatellar approach was routinely used, with a 
lateral parapatellar approach and osteotomy of the tibial 
tubercle in cases with severe valgus deformity. Cemented 
primary implants (LCS complete or Attune, DePuy-Syn-
thes) were implanted in all cases. A tibia first, ligament 
balancing technique was employed, with and without 
computer-navigation (Brainlab, Munich). The cruciate 
ligaments were routinely sacrificed. No special considera-
tions were made for patients based on their BMI during 
the routine postoperative standard rehab protocol, which 
was followed in every case. This allowed unrestricted 
weight bearing as tolerated on crutches and physiother-
apy to improve range of motion and muscle activation 
without further limitations from day one. VTE prophy-
laxis was performed for 6 weeks following surgery. Out-
patient follow-up visits were routinely performed 2 and 
12 months postoperatively, and in 5-year intervals there-
after. Preoperative and 12-month postoperative data 
were retrieved. Patient reported outcome data were pro-
spectively collected at the time of treatment. The West-
ern Ontario and McMaster Universities Osteoarthritis 
Index (WOMAC score) was employed for measuring 
pain, stiffness and function in the respective subscales, 
the EQ-5D for measuring general health status. The 
WOMAC score is a widely used three-dimension self-
administered patient-reported outcome instrument con-
sisting of 24 questions that are linearly transformed to 
a 0–100 scale with higher scores indicating more severe 
impairment. The score has been extensively tested for 
validity, reliability, feasibility and responsiveness [30, 31]. 
The EQ-5D [32] is a generic self-report questionnaire. It 
consists of five questions measuring the patient’s health 
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status and covers self-care, mobility, depression/anxiety, 
pain and usual activities. A health utility can be calcu-
lated from the five questions, with a score of 1 reflecting 
full health, 0 indicating a health state equaling death and 
negative values describing health states that patients con-
sider worse than being dead. This widely used question-
naire has shown satisfying measurement characteristics 
in knee patients [33].
Statistical analysis
Sample characteristics are given as means, standard 
deviations or 95% confidence intervals, and ranges. Score 
change following surgery was compared across the BMI 
categories identified by the World Health Organization 
(WHO) [13]: normal weight (BMI < 25.00), overweight 
(BMI 25.00 to 29.99), class I obesity (BMI 30.00 to 34.99), 
class II obesity (BMI 35.00 to 39.99), and class III obesity 
(BMI ≥ 40.00).
To investigate the impact of BMI on postoperative 
improvement we used linear mixed models with the 
outcome parameters (WOMAC subscales, EQ-5D) as 
dependent variables, and the following independent vari-
ables: BMI group, time point (preoperative and 12-month 
follow-up), and the two-way interaction of group-by-
time. In such a model, the interaction term indicates a 
difference in postoperative improvement between BMI 
groups. We ran pairwise post-hoc tests comparing post-
operative improvement between the “normal weight” cat-
egory and the four other BMI categories. The models also 
included a first-order autoregressive covariance matrix 
to account for correlations between repeated measure-
ments. Results are presented as estimated marginal 
means with their 95% confidence intervals and p-values 
for the group effect, time effect, and the group-by-time 
interaction. P-values below 0.05 were considered to be 




Between February 2006 and December 2016, a total of 
2172 patients underwent primary TKA at our institution 
Fig. 1 Flowchart on study inclusion
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and were included in the local knee arthroplasty reg-
istry. 1565 patients were available for analysis (Fig.  1). 
There were no statistically significant differences between 
patients having or missing BMI or PROMs data, indi-
cating that these missing values were random (data not 
shown).
In this sample, mean patient age was 69.1 years (range 
24.8—92.3 years). 62.2% of patients were female, and the 
right side was affected in 817 cases (52.2%). Response 
rates for the WOMAC score and the EQ-5D at 12-month 
were 83.8% and 84.5%, respectively. We found 21.2% of 
patients (N = 332) to be normal weight (BMI < 25.0  kg/
m2), 36.9% (N = 578) were overweight (BMI 25.0–
29.9  kg/m2), 27.0% (N = 423) had class I obesity (BMI 
30.0–34.9  kg/m2), 10.2% (N = 160) had class II obesity 
(BMI 35.0–39.9  kg/m2), and 4.6% (N = 72) had class III 
obesity (BMI ≥ 40.0 kg/m2) (Table 1).
BMI was associated with sex (p < 0.001), with a similar 
proportion of normal weight patients for both sexes (men 
20.5% vs women 21.7%), a higher proportion of pre-obese 
men (men 43.3% vs women 33.1%), and more women in 
class I-III obesity (class I: 27.9% women vs 25.5% men, 
class II 12.2% women vs 6.9% men, class III: 5.1% women 
vs 3.7% men).
There was a statistically significant association of BMI 
class and age at the time of surgery (p < 0.001). Mean age 
was 70.5 years in normal weight patients and decreased 
monotonously to 65.3 years in class III obesity patients.
WOMAC pain
WOMAC pain scores differed significantly between 
BMI groups (p < 0.001) with better scores observed in 
lower BMI categories. Pain scores improved between 
preoperative assessments and 12-month follow-up 
(p < 0.001). Postoperative improvement was associated 
with BMI group (p < 0.001). In pairwise comparisons of 
BMI groups, we found improvements in class I, II and III 
obesity patients (-40.4, -44.2, and -42.3 points) to be sta-
tistically significantly (all p < 0.05) larger than in normal 
weight patients (-34.5 points). For further details please 
see Table 2 and Fig. 2a. All differences remained statisti-
cally significant when adjusting for sex and age.
WOMAC function
WOMAC function scores differed significantly between 
BMI groups (p < 0.001), with lower BMI groups show-
ing better function. Function significantly improved 
from pre-surgery to the 12-month follow-up (p < 0.001). 
Postoperative improvement was also associated with 
BMI group (p = 0.030). The pairwise comparisons of 
BMI groups, showed improvements in class I-II obe-
sity patients (-41.6 and -42.3 points) to be statistically 
significantly (both p < 0.05) larger than in normal weight 
patients (-36.4 points). Further details are given in 
Table 2 and Fig. 2b. In sex-and age-adjusted analysis all 
differences remained statistically significant.
WOMAC total
For the WOMAC total score we found statistically 
significant differences between BMI groups over-
all (p < 0.001) with patients with lower BMI report-
ing better scores, and a general improvement between 
the preoperative time point and 12-month follow-up 
(p < 0.001).
Table 1 Sociodemographic and clinical patient characteristics at 
pre-surgery (N = 1565)





 Women 974 (62.2%)
 Men 591 (37.8%)
Education
 Compulsory school 479 (31.2%)






 Full-time or part-time 293 18.9%
 Retired 730 47.1%
 Homemaker 448 28.9%
 Other 51 5.1%
 Missing 16
Smoking
 No 1277 (82.6%)
 Yes 269 (17.4%)
 Missing 19
Side of implant
 Left 748 (47.8%)
 Right 817 (52.2%)
BMI (%)
  ≤ 24.99 normal weight 332 (21.2%)
 25.00–29.99 pre-obesity 578 (36.9%)
 30.00–34.99 class I obesity 423 (27.0%)
 35.00–39.99 class II obesity 160 (10.2%)
  ≥ 40.00 class III obesity 72 (4.6%)
Computer navigation
 Yes 931 61.0%
  Noa 595 39.0%
 Missing 39
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For the WOMAC total score, postoperative improve-
ment was associated with BMI group (p = 0.006). 
The pairwise comparisons of BMI groups showed 
statistically significantly (all p < 0.05) larger improve-
ments in class I-II obesity patients (-41.0 and -42.4 
points) compared to normal weight patients (-35.8 
Table 2 WOMAC pain, function and total score for different BMI groups (pre-surgery: all scales N = 1565; 12-month: pain N = 1311, 
function N = 1308, total N = 1308)
a  statistically significant (p < 0.05) difference in change compared to “normal” weight patients
Pre-surgery 12 months Improvement
BMI Mean (95%CI) Mean (95%CI) Mean (95%CI)
WOMAC pain
normal: < 25 45.2 (38.7–51.7) 10.7 (2.9–18.5) 34.5 (31.9–37.1)
pre-obesity: 25–30 45.9 (39.3–52.6) 9.8 (3.7–16.0) 36.1 (34.1–38.1)
class I obesity: 30–35 50.5 (43.7–57.2) 10.1 (3.6–16.6) 40.4 (38.0–42.7)*
class II obesity: 35–40 54.3 (41.8–66.8) 10.2 (0.0–22.9) 44.2 (40.3–48.0)*
class III obesity: ≥ 40 54.9 (39.1–70.7) 12.6 (0.0–29.2) 42.3 (36.7–48.0)*
Group Time Group-by-time interaction
F = 6.1; p < 0.001 F = 2458.4; p < 0.001 F = 6.7; p < 0.001
WOMAC function
normal: < 25 52.6 (50.6–54.6) 16.2 (14.0–18.4) 36.4 (33.8–39.1)
pre-obesity: 25–30 54.5 (53.0–56.0) 15.5 (13.9–17.1) 39.0 (37.0–41.0)
class I obesity: 30–35 57.7 (56.0–59.5) 16.2 (14.3–18.1) 41.6 (39.2–43.9)*
class II obesity: 35–40 61.1 (58.2–63.9) 18.7 (15.6–21.9) 42.3 (38.5–46.2)*
class III obesity: ≥ 40 62.8 (58.6–67.1) 22.4 (17.8–27.0) 40.4 (34.8–46.1)
Group Time Group-by-time interaction
F = 8.0; p < 0.001 F = 2497.6; p < 0.001 F = 2.7; p = 0.030
WOMAC total
normal: < 25 50.9 (49.0–52.8) 15.1 (13.1–17.2) 35.8 (33.3–38.3)
pre-obesity: 25–30 52.6 (51.1–54.0) 14.5 (13.0–16.0) 38.1 (36.2–39.9)
class I obesity: 30–35 56.0 (54.3–57.6) 14.9 (13.1–16.7) 41.0 (38.8–43.2)a
class II obesity: 35–40 59.1 (56.4–61.8) 16.7 (13.7–19.6) 42.4 (38.8–46.1)a
class III obesity: ≥ 40 60.8 (56.8–64.8) 20.2 (15.8–24.5) 40.6 (35.3–46.0)
Group Time Group-by-time interaction
F = 7.4; p < 0.001 F = 2739.4; p < 0.001 F = 3.6; p = 0.006
A B
Fig. 2 WOMAC pain (a) and function (b) score change between pre-surgery and 12-month follow-up across BMI groups
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points). Details are given in Table  2. In sex-and age-
adjusted analysis all differences remained statistically 
significant.
EQ-5D
The EQ-5D utility scores differed between BMI groups 
(p < 0.001), and improved in general from preoperatively 
to 12-month follow-up (p < 0.001). No statistically sig-
nificant difference between BMI groups was observed 
regarding postoperative improvement (p = 0.066). 
Adjustment for sex and age resulted in the same statisti-
cal differences (Table 3).
Discussion
This study highlights that the perceived benefit in terms 
of joint-specific patient-reported outcome following total 
knee arthroplasty is larger in obese patients compared to 
normal weight patients when analyzing post-operative 
improvement at 12-month follow-up. This association 
was found irrespective of a possible impact of sex and 
age.
The literature on the impact of BMI on pain and func-
tional outcomes following TKA is somewhat conflicted. 
Multiple studies have shown that outcomes after TKA are 
worse in obese patients than in non-obese patients [10, 
18, 34]. Amin et al. [34] reported inferior cross-sectional 
clinical outcome scores (Knee Society Score) and higher 
complication rates in morbidly obese patients at a mean 
follow-up of 38.5  months. They reported a significantly 
higher rate of radiolucent lines around the implants 
(notably around the tibial component) and inferior five-
year implant survivorship for patients with BMI > 40 kg/
m2 compared to patients with BMI < 30  kg/m2 in their 
prospective matched pair study. Lash et  al. [35] found 
that patients with BMI > 35  kg/m2 had worse preop-
erative and post-operative functional scores (WOMAC, 
Oxford Knee Score, High-activity Arthroplasty Score) 
than patients with BMI < 30 kg/m2, but their benefit from 
surgery measured by the change in functional scores 
showed no difference. Similarly, Baker et al. [19] reported 
no differences in OKS improvement among patients with 
class I, II and III obesity.
In line with our results, Chen et al. [17] suggest greater 
improvement in the more obese patient groups, with the 
mean improvement in Oxford Knee Score (OKS) and 
Knee Society Knee Score (KSKS) at two years follow-up 
being significantly higher in the morbidly obese group 
than in the normal group. Greater obesity level was asso-
ciated with more pain at baseline but greater postopera-
tive pain relief in a study conducted by Li et al. [27]. In 
this study, the postoperative gain in Physical Component 
Summary (SF-36) did not differ by BMI level.
Similarly, a recent systematic review by Boyce et  al. 
[6] found that all patients regardless of BMI experi-
enced comparable improvements in knee function fol-
lowing TKA.
The more obese patients in our cohort generally 
reported a superior improvement in outcome scores. 
The context of this improvement is that they started 
with notably poorer preoperative scores. As such 
although the delta (improvement) was larger, the abso-
lute post-operative score was not superior in the obese 
patients. When evaluating the clinical benefits of TKA 
it is crucial to focus on change rather than interpret 
post-operative data with cross-sectional analysis, as the 
latter may to a large degree simply reflect pre-operative 
differences between patients. Change in symptomatol-
ogy is what is most noticeable to the patient and is the 
yardstick by which they interpret the benefit of surgery 
and patients with higher pre-operative symptom bur-
den may have simply more to gain by surgery.
It is important to note that this study did not take 
into account the increased complication rate in obese 
patients associated with the intervention. Higher peri-
operative and postoperative complication risks are 
well accepted to be greater in obese patients [20, 25, 
34, 36]. Complication rates climb further as BMI levels 
rise into morbidly and super-obese categories [6, 10, 
Table 3 EQ-5D utility values for different BMI groups (pre-surgery N = 1521, 12-month N = 1286)
No statistically significant (p < 0.05) differences in change between BMI groups
EQ-5D utility Pre-surgery 12 months Improvement
BMI Mean (95%CI) Mean (95%CI) Mean (95%CI)
normal: < 25 0.66 (0.49–0.83) 0.90 (0.31–1.00) 0.24 (0.21–0.27)
pre-obesity: 25–30 0.66 (0.55–0.77) 0.90 (0.79–1.00) 0.24 (0.22–0.26)
class I obesity: 30–35 0.61 (0.45–0.77) 0.89 (0.71–1.00) 0.28 (0.25–0.31)
class II obesity: 35–40 0.58 (0.11–1.00) 0.86 (0.12–1.00) 0.28 (0.23–0.33)
class III obesity: ≥ 40 0.54 (-0.09–1.00) 0.85 (-0.09–1.00) 0.30 (0.24–0.37)
Group Time Group-by-time interaction
F = 9.1; p < 0.001 F = 785.9; p < 0.001 F = 2.2; p = 0.066
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37]. Increased risks include wound related problems 
like delayed wound healing, superficial wound infec-
tion and deep prosthetic joint infection [6, 22, 25, 34, 
36, 38]. In addition, obese patients show higher rates 
of revision, aseptic loosening and radiographic signs 
of early loosening [6, 34, 38, 39] and more frequent 
osteolysis or wear [39]. Alongside reduced longevity 
of the implant, obesity is also associated with reduced 
life expectancy [40–42]. Patients with BMIs over 35 
can expect a significantly reduced life expectancy 
compared to normal weight individuals. Large scale 
international study data suggests around 3–4 years are 
lost to individuals with class I obesity and 10 or more 
years to those in class III [43–45]. If hesitation to per-
form surgery in obese patients is due to concerns as to 
reduced implant longevity, this worry may be partially 
mitigated by a generally reduced life expectancy. In 
terms of health economy, even in “high risk” patients, 
TKA remains a cost-effective intervention [46].
From a clinical perspective, joint replacement sur-
gery is an intervention for end-stage disease. Our 
findings also support a developmental relationship 
between OA and obesity, as highly obese patients 
underwent TKA at a younger age than the normal 
weight or pre-obese patient population. These con-
siderations are in accordance with the findings of 
Changulani et al. [47] who stated that for both hip and 
knee replacement, the age at surgery fell significantly 
for patients with a BMI > 35 kg/m2. It is also likely that 
the management of increased complications in this 
population predispose obese patients rather toward a 
delay of arthroplasty, and it is likely they present even 
younger to orthopedics than the age at time of surgery 
suggests.
Strengths of this study include a large sample size 
which allowed for stratification and comparison of 
BMI subgroups as suggested by the WHO, the availa-
bility of data from a joint-specific questionnaire as well 
as a general health outcome measure which allowed 
to demonstrate the differential impact of BMI on out-
come after TKA. A limitation is that we had a 28% loss 
to follow-up rate, 12.6% of patients had to be excluded 
due to missing PROM questionnaires and 10.9% of 
patients due to missing BMI values (Fig. 1). However, 
as collection of BMI values and PROM questionnaires 
in our series is largely unrelated to BMI category it is 
unlikely that this may have introduced relevant bias in 
this study. Another limitation is that the patients’ BMI 
was only recorded preoperatively and possible weight 
changes that may have taken place by the 12-month 
postoperative review were not accounted for. This 
is potentially important in the light that patients 
who underwent TKA and lost weight thereafter were 
reported to have better clinical outcome scores than 
patients who gained weight in the postoperative period 
[48]. However, recent literature indicates the patient’s 
bodyweight to be maintained after TKA [49–51], sug-
gesting a minor possible impact of weight change on 
our results. The percentage of patients in obesity class 
II and III was relatively low, compared to reports in 
other countries with two-thirds of our patient cohort 
clustered in the overweight / pre-obese and class I 
obese categories. This however accurately reflects our 
wider country-specific weight distribution.
Conclusions
This study demonstrates larger post-operative improve-
ment in joint-specific outcomes in obese patients com-
pared to normal weight patients. Our findings suggest 
that obese patients may have the greatest benefits from 
TKA regarding increase of functional capacity and pain 
relief at one year follow-up. Well balanced treatment 
decisions in shared decision making should fully account 
for both: Higher benefits in terms of pain relief and func-
tion as well as increased potential risks and complications 
after TKA.
Abbreviations
OA: Osteoarthritis; TKA: Total knee arthroplasty; BMI: Body Mass Index; WHO: 
World Health Organisation; WOMAC: Western Ontario and McMaster Universi-





KG and JMG were involved in conceptualization and design of the study. AL, 
DH, JR and KG were involved in analysis and interpretation of the data. AL and 
JMG were drafting the manuscript. All authors edited, read and approved the 
final manuscript.
Funding
No direct support for this project was received.
Availability of data and materials
The datasets generated and analysed during the current study are not publicly 
available as access to the relevant institutional database is restricted to the 
public, but data are available from the corresponding author on reasonable 
request.
Declarations
Ethics approval and consent to participate
Ethics approval for this study was obtained from the Ethics Committee of East-
ern Switzerland EKOS (Ethikkommission Ostschweiz; trial registration number 
2020–00879 from 16.04.2020). All methods were carried out in accordance 
with relevant guidelines and regulations.All patients provided informed con-
sent to take part in the study.
Consent for publication
All patients provided informed consent to take part in the study.
Page 8 of 9Giesinger et al. BMC Musculoskelet Disord          (2021) 22:635 
Competing interests
DH reports research support from Stryker and to have held paid presentations 
for the same company. The other authors declare that they have no compet-
ing interests.
Author details
1 Department of Orthopaedics and Traumatology, Kantonsspital St. Gallen, 
Rorschacherstrasse 95, 9007 St. Gallen, Switzerland. 2 Innsbruck Institute 
of Patient-Centered Outcome Research (IIPCOR), Innsbruck, Austria. 3 School 
of Health and Social Care, Edinburgh Napier Univ, ersity, Edinburgh, Scotland. 
Received: 24 November 2020   Accepted: 2 July 2021
References
 1. Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoar-
thr Cartil. 2013;21(9):1145–53. [cited 2020 Apr 14] Available from: http:// 
www. ncbi. nlm. nih. gov/ pubmed/ 23973 124
 2. Feng JE, Novikov D, Anoushiravani AA, Schwarzkopf R. Total knee 
arthroplasty: Improving outcomes with a multidisciplinary approach. J 
Multidisciplinary Healthcare. 2018;11:63–73.
 3. Hamilton D, Henderson GR, Gaston P, MacDonald D, Howie C, Simpson 
AHRW. Comparative outcomes of total hip and knee arthroplasty: A pro-
spective cohort study. Postgrad Med J. 2012;88(1045):627–31. [cited 2020 
Aug 29] Available from: https:// pubmed. ncbi. nlm. nih. gov/ 22822 221/
 4. National Joint Registry 15th Annual Report 2018 – HQIP. [cited 2020 Aug 
29]. Available from: https:// www. hqip. org. uk/ resou rce/ natio nal- joint- regis 
try- 15th- annual- report- 2018/#. X0o- aNMzb uw
 5. Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR. Total knee arthroplasty 
volume, utilization, and outcomes among medicare beneficiaries, 
1991–2010. JAMA - J Am Med Assoc. 2012;308(12):1227–36. [cited 2020 
Aug 29] Available from: www. jama. com.
 6. Boyce L, Prasad A, Barrett M, Dawson-Bowling S, Millington S, Hanna SA, 
et al. The outcomes of total knee arthroplasty in morbidly obese patients: 
a systematic review of the literature. Arch Orthopaedic Trauma Surg. 
2019;139:553–60. [cited 2020 Apr 13] Available from: https:// doi. org/ 10. 
1007/ s00402- 019- 03127-5
 7. Bonasia DE, Palazzolo A, Cottino U, Saccia F, Mazzola C, Rosso F, et al. 
Modifiable and nonmodifiable predictive factors associated with the 
outcomes of total knee arthroplasty. Joints. 2019;7(1):13–8.
 8. Xu S, Chen JY, Lo NN, Chia SL, Tay DKJ, Pang HN, et al. The influence of 
obesity on functional outcome and quality of life after total knee arthro-
plasty. Bone Jt J. 2018;100B(5):579–83.
 9. Keeney BJ, Austin DC, Jevsevar DS. Preoperative Weight Loss for Morbidly 
Obese Patients Undergoing Total Knee Arthroplasty: Determining the 
Necessary Amount. J Bone Jt Surg - Am Vol. 2019;101(16):1440–50. [cited 
2021 Mar 31] Available from: https:// pubmed. ncbi. nlm. nih. gov/ 31436 
651/
 10. Martin JR, Jennings JM, Dennis DA. Morbid obesity and total knee arthro-
plasty: A growing problem. Vol. 25, Journal of the American Academy of 
Orthopaedic Surgeons. Lippincott Williams and Wilkins; 2017; 188–94. 
[cited 2020 Apr 13] Available from: http:// www. ncbi. nlm. nih. gov/ pub-
med/ 28146 438
 11. Gandhi R, Wasserstein D, Razak F, Davey JR, Mahomed NN. BMI inde-
pendently predicts younger age at hip and knee replacement. Obesity. 
2010;18(12):2362–6. [cited 2020 Apr 10] Available from: http:// www. ncbi. 
nlm. nih. gov/ pubmed/ 20379 147
 12. Di Cesare M, Bentham J, Stevens GA, Zhou B, Danaei G, Lu Y, et al. Trends 
in adult body-mass index in 200 countries from 1975 to 2014: A pooled 
analysis of 1698 population-based measurement studies with 19.2 mil-
lion participants. Lancet. 2016 Apr 2;387(10026):1377–96.
 13. Uccioli L, Monticone G, Russo F, Mormile F, Durola L, Mennuni G, et al. 
OBESITY: PREVENTING AND MANAGING THE GLOBAL EPIDEMIC. WHO 
Tech Rep Ser. 1994;37(10):1051–5. [cited 2020 Apr 7] Available from: 
https:// www. who. int/ nutri tion/ publi catio ns/ obesi ty/ WHO_ TRS_ 894/ en/
 14. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. 
National, regional, and global trends in body-mass index since 1980: 
Systematic analysis of health examination surveys and epidemiological 
studies with 960 country-years and 9·1 million participants. Lancet. 
2011;377(9765):557–67.
 15. Wang Y, Chen X. How Much of Racial/Ethnic Disparities in Dietary 
Intakes, Exercise, and Weight Status Can Be Explained by Nutrition- and 
Health-Related Psychosocial Factors and Socioeconomic Status among 
US Adults? J Am Diet Assoc. 2011;111(12):1904–11. [cited 2020 Aug 29] 
Available from: https:// pubmed. ncbi. nlm. nih. gov/ 22117 667/
 16. Si H bo, Zeng Y, Shen B, Yang J, Zhou Z ke, Kang P de, et al. The influence 
of body mass index on the outcomes of primary total knee arthroplasty. 
Vol. 23, Knee Surgery, Sports Traumatology, Arthroscopy. Springer Verlag; 
2015; 1824–32. [cited 2020 Apr 14] Available from: http:// www. ncbi. nlm. 
nih. gov/ pubmed/ 25217 315
 17. Chen JY, Lo NN, Chong HC, Bin Abd Razak HR, Pang HN, Tay DKJ, et al. The 
influence of body mass index on functional outcome and quality of life 
after total knee arthroplasty. Bone Jt J. 2016;98-B(6):780–5. [cited 2020 
Apr 13] Available from: http:// www. ncbi. nlm. nih. gov/ pubmed/ 27235 520
 18. Abdel MP, Bonadurer GF, Jennings MT, Hanssen AD. Increased Aseptic 
Tibial Failures in Patients With a BMI ≥35 and Well-Aligned Total Knee 
Arthroplasties. J Arthroplasty. 2015;30(12):2181–4. [cited 2020 Apr 13] 
Available from: http:// www. ncbi. nlm. nih. gov/ pubmed/ 26220 103
 19. Baker P, Petheram T, Jameson S, Reed M, Gregg P, Deehan D. The 
association between body mass index and the outcomes of total knee 
arthroplasty. J Bone Joint Surg Am. 2012;94(16):1501–8. [cited 2020 Apr 
13] Available from: http:// www. ncbi. nlm. nih. gov/ pubmed/ 22992 819
 20. Kerkhoffs GMMJ, Servien E, Dunn W, Dahm D, Bramer JAM, Haverkamp 
D. The influence of obesity on the complication rate and outcome of 
total knee arthroplasty: A meta-analysis and systematic literature review. 
J Bone Jt Surg - Ser A. 2012;94(20):1839–44. [cited 2020 Apr 13] Available 
from: http://dx.doi.org/https:// doi. org/ 10. 2106/ JBJS.K. 00820
 21. Rissman CM, Keeney BJ, Ercolano EM, Koenig KM. Predictors of Facility 
Discharge, Range of Motion, and Patient-Reported Physical Function 
Improvement After Primary Total Knee Arthroplasty: A Prospective Cohort 
Analysis. J Arthroplasty. 2016;31(1):36–41. [cited 2021 Mar 31] Available 
from: /pmc/articles/PMC4691374/
 22. D’Apuzzo MR, Novicoff WM, Browne JA. The John Insall Award: Morbid 
Obesity Independently Impacts Complications, Mortality, and Resource 
Use After TKA. Clin Orthop Relat Res. 2015;473(1):57–63. [cited 2021 Mar 
31] Available from: https:// pubmed. ncbi. nlm. nih. gov/ 24818 736/
 23. Sun K, Li H. Body mass index as a predictor of outcome in total knee 
replace: A systemic review and meta-analysis. Knee. 2017;24(5):917–24. 
[cited 2020 Aug 29] Available from: https:// pubmed. ncbi. nlm. nih. gov/ 
28666 646/
 24. Adhikary SD, Liu WM, Memtsoudis SG, Davis CM, Liu J. Body Mass Index 
More Than 45 kg/m2 as a Cutoff Point Is Associated With Dramatically 
Increased Postoperative Complications in Total Knee Arthroplasty and 
Total Hip Arthroplasty. J Arthroplasty. 2016;31(4):749–53. [cited 2020 Apr 
14] Available from: http:// www. ncbi. nlm. nih. gov/ pubmed/ 26652 477
 25. Bordini B, Stea S, Cremonini S, Viceconti M, De Palma R, Toni A. Relation-
ship between obesity and early failure of total knee prostheses. BMC 
Musculoskelet Disord. 2009;10:29.
 26. Keeney BJ, Koenig KM, Paddock NG, Moschetti WE, Sparks MB, Jevsevar 
DS. Do Aggregate Socioeconomic Status Factors Predict Outcomes 
for Total Knee Arthroplasty in a Rural Population? J Arthroplasty. 
2017;32(12):3583–90. [cited 2021 Mar 31] Available from: /pmc/articles/
PMC5693700/
 27. Li W, Ayers DC, Lewis CG, Bowen TR, Allison JJ, Franklin PD. Functional 
Gain and Pain Relief after Total Joint Replacement According to Obesity 
Status. J Bone Jt Surg - Am Vol. 2017;99(14):1183–9. [cited 2020 Aug 29] 
Available from: https:// pubmed. ncbi. nlm. nih. gov/ 28719 557/
 28. Collins JE, Donnell-Fink LA, Yang HY, Usiskin IM, Lape EC, Wright J, et al. 
Effect of Obesity on Pain and Functional Recovery Following Total Knee 
Arthroplasty. J Bone Joint Surg Am. 2017;99(21):1812–8. [cited 2020 Aug 
29] Available from: https:// pubmed. ncbi. nlm. nih. gov/ 29088 035/
 29. Giesinger JM, Loth FL, MacDonald DJ, Giesinger K, Patton JT, Simpson 
AHRW, et al. Patient-reported outcome metrics following total knee 
arthroplasty are influenced differently by patients’ body mass index. Knee 
Surgery, Sport Traumatol Arthrosc. 2018;26(11):3257–64. [cited 2020 Apr 
14] Available from: http:// www. ncbi. nlm. nih. gov/ pubmed/ 29417 168
 30. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Valida-
tion study of WOMAC: a health status instrument for measuring 
clinically important patient relevant outcomes to antirheumatic drug 
Page 9 of 9Giesinger et al. BMC Musculoskelet Disord          (2021) 22:635  
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 
1988;15(12):1833–40. [cited 2018 Jul 16] Available from: http:// www. ncbi. 
nlm. nih. gov/ pubmed/ 30683 65
 31. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal 
clinically important differences of rehabilitation intervention with their 
implications for required sample sizes using WOMAC and SF-36 quality of 
life measurement instruments in patients with osteoarthritis of the lower 
ex. Arthritis Rheum. 2001;45(4):384–91.
 32 The EuroQol Group. EuroQol - a new facility for the measurement of 
health-related quality of life. Health Policy (New York). 1990;16(3):199–208.
 33. Conner-Spady BL, Marshall DA, Bohm E, Dunbar MJ, Loucks L, Khudairy 
A Al, et al. Reliability and validity of the EQ-5D-5L compared to the EQ-
5D-3L in patients with osteoarthritis referred for hip and knee replace-
ment. Qual Life Res. 2015;24(7):1775–84. [cited 2020 Apr 7] Available 
from: http:// www. ncbi. nlm. nih. gov/ pubmed/ 25555 837
 34. Amin AK, Clayton RAE, Patton JT, Gaston M, Cook RE, Brenkel IJ. Total 
knee replacement in morbidly obese patients: Results of a prospective, 
matched study. J Bone Jt Surg - Ser B. 2006;88(10):1321–6. [cited 2020 Apr 
13] Available from: http:// www. ncbi. nlm. nih. gov/ pubmed/ 17012 421
 35. Lash H, Hooper G, Hooper N, Frampton C. Should a Patients BMI Status 
be Used to Restrict Access to Total Hip and Knee Arthroplasty? Functional 
Outcomes of Arthroplasty Relative to BMI - Single Centre Retrospective 
Review. Open Orthop J. 2013;7(1):594–9.
 36. Dewan A, Bertolusso R, Karastinos A, Conditt M, Noble PC, Parsley BS. 
Implant Durability and Knee Function After Total Knee Arthroplasty in the 
Morbidly Obese Patient. J Arthroplasty. 2009;24(6 SUPPL.):89–94, 94.e1–3. 
[cited 2020 Apr 13] Available from: http:// www. ncbi. nlm. nih. gov/ pub-
med/ 19576 727
 37. Werner BC, Evans CL, Carothers JT, Browne JA. Primary Total Knee 
Arthroplasty in Super-obese Patients: Dramatically Higher Postoperative 
Complication Rates Even Compared to Revision Surgery. J Arthroplasty. 
2015;30(5):849–53. [cited 2020 Apr 13] Available from: http:// www. ncbi. 
nlm. nih. gov/ pubmed/ 25577 726
 38. Naziri Q, Issa K, Malkani AL, Bonutti PM, Harwin SF, Mont MA. Bariatric 
orthopaedics: Total knee arthroplasty in super-obese patients (BMI > 
50 kg/m 2 ). Survivorship and complications. Clin Orthop Relat Res. 
2013;471(11):3523–30.
 39. Krushell RJ, Fingeroth RJ. Primary Total Knee Arthroplasty in Morbidly 
Obese Patients. A 5- to 14-Year Follow-up Study. J Arthroplasty. 2007;22(6 
SUPPL.):77–80. [cited 2020 Apr 13] Available from: http:// www. ncbi. nlm. 
nih. gov/ pubmed/ 17823 021
 40. Jia H, Zack MM, Thompson WW. Population-based estimates of decreases 
in quality-adjusted life expectancy associated with unhealthy body mass 
index. Public Health Rep. 2016;131(1):177–84. [cited 2020 Jun 20] Avail-
able from: /pmc/articles/PMC4716486/?report=abstract
 41. Lung T, Jan S, Tan EJ, Killedar A, Hayes A. Impact of overweight, obesity 
and severe obesity on life expectancy of Australian adults. Int J Obes. 
2019;43(4):782–9. [cited 2020 Jun 20] Available from: https:// pubmed. 
ncbi. nlm. nih. gov/ 30283 076/
 42. Finkelstein EA, Brown DS, Wrage LA, Allaire BT, Hoerger TJ. Individual and 
aggregate years-of-life-lost associated with overweight and obesity. 
Obesity (Silver Spring). 2010;18(2):333–9. [cited 2020 Jun 20] Available 
from: http:// www. ncbi. nlm. nih. gov/ pubmed/ 19680 230
 43. MacMahon S, Baigent C, Duffy S, Rodgers A, Tominaga S, Chamb-
less L, et al. Body-mass index and cause-specific mortality in 900 
000 adults: Collaborative analyses of 57 prospective studies. Lancet. 
2009;373(9669):1083–96. [cited 2020 Aug 29] Available from: http:// www. 
ctsu.
 44. Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, et al. Associa-
tion of body mass index with lifetime risk of cardiovascular disease and 
compression of morbidity. JAMA Cardiol. 2018;3(4):280–7. [cited 2020 
Aug 29] Available from: /pmc/articles/PMC5875319/?report=abstract
 45. Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Associa-
tion of BMI with overall and cause-specific mortality: a population-based 
cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 
2018;6(12):944–53. [cited 2020 Aug 29] Available from: www. thela ncet. 
com/ diabe tes- endoc rinol ogy
 46. Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, 
et al. Cost-effectiveness of total knee arthroplasty in the United States: 
Patient risk and hospital volume. Arch Intern Med. 2009;169(12):1113–21. 
[cited 2020 Apr 13] Available from: http:// www. ncbi. nlm. nih. gov/ pub-
med/ 19546 411
 47. Changulani M, Kalairajah Y, Peel T, Field RE. The relationship between 
obesity and the age at which hip and knee replacement is undertaken. J 
Bone Jt Surg - Ser B. 2008;90(3):360–3.
 48. Ast MP, Abdel MP, Lee Y, Lyman S, Ruel A V., Westrich GH. Weight Changes 
After Total Hip or Knee Arthroplasty. J Bone Jt Surg. 2015;97(11):911–9. 
[cited 2021 Mar 31] Available from: https:// journ als. lww. com/ 00004 623- 
20150 6030- 00005
 49. Razzaki T, Mak WK, Bin Abd Razak HR, Tan HCA. Patterns of Weight Change 
and Their Effects on Clinical Outcomes Following Total Knee Arthroplasty 
in an Asian Population. J Arthroplasty. 2020;35(2):375–9. [cited 2020 Apr 
14] Available from: http:// www. ncbi. nlm. nih. gov/ pubmed/ 31563 395
 50. Schwartsmann CR, Borges AM, Freitas GLS de, Migon EZ, Oliveira GK de, 
Rodrigues MW. Do patients lose weight after total knee replacement? 
Rev Bras Ortop (English Ed. 2017;52(2):159–63. [cited 2020 Apr 14] Avail-
able from: http:// www. ncbi. nlm. nih. gov/ pubmed/ 28409 132
 51. Kandil A, Novicoff WM, Browne JA. Obesity and total joint arthro-
plasty: Do patients lose weight following surgery? Phys Sportsmed. 
2013;41(2):34–7. [cited 2020 Apr 14] Available from: http:// www. ncbi. nlm. 
nih. gov/ pubmed/ 23703 515
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
